AMD Lasers has introduced LEAP (Laser Endodontic Ablation Procedure), a diode laser system that achieves greater than 99.99% bacterial elimination in root canals. The technology, which received FDA clearance and debuted at the 2026 AAE Annual Meeting, combines a Picasso Pro diode laser with proprietary disinfection solution and engineered fibre tips to streamline endodontic disinfection workflows.
As of June 2026, endodontic disinfection remains one of the most technically demanding steps in root canal therapy. Persistent bacteria — particularly Enterococcus faecalis — are a leading cause of treatment failure, retreatment, and post-operative complications. Traditional sodium hypochlorite irrigation, while effective, has well-documented limitations in reaching complex canal anatomy, lateral canals, and apical ramifications.
AMD Lasers, an Arizona-based manufacturer specializing in dental diode lasers, has responded with a system that could reshape how general dentists and endodontists approach canal disinfection.
What Is LEAP and How Does It Work?
LEAP stands for Laser Endodontic Ablation Procedure. The system integrates three components into a single protocol:
- Picasso Pro diode laser — a compact, portable unit that generates targeted laser energy at wavelengths optimized for bacterial destruction in soft tissue environments
- Proprietary LEAP disinfection solution — a chemical agent designed to work synergistically with the laser energy, enhancing penetration into dentinal tubules
- Engineered LEAP fibre tips — specially designed delivery fibres that distribute laser energy uniformly throughout the canal system
The combined effect is a photothermal and photochemical reaction that penetrates deeper into dentinal tubules than irrigants alone can reach. Independent laboratory testing demonstrated greater than 99.99% bacterial reduction against Enterococcus faecalis, one of the most treatment-resistant pathogens in endodontic infections.
Why This Matters for Canadian Dental Practices
For dental professionals in Toronto, the Greater Toronto Area, and across Ontario, the implications are significant. The Royal College of Dental Surgeons of Ontario (RCDSO) mandates that dentists follow evidence-based infection prevention and control (IPAC) protocols in all clinical procedures, including endodontic therapy. A system that demonstrably eliminates 99.99% of canal bacteria strengthens a practice's compliance posture while potentially improving long-term treatment outcomes.
Retreatment rates for root canal therapy have been a persistent concern. Studies published in the Journal of Endodontics suggest that 5-15% of primary root canal treatments require retreatment within 10 years, often due to residual infection. If LEAP's laboratory results translate to clinical practice, practices could see meaningful reductions in retreatment frequency — which affects both patient outcomes and practice economics.
Pro Tip: Track your practice's retreatment rate over 12 months before adopting any new disinfection technology. This baseline gives you a concrete metric to evaluate whether the investment delivers measurable clinical improvement.
Clinical Workflow Integration
One of LEAP's practical advantages is its integration into existing endodontic workflows. The system does not require practitioners to abandon their current irrigation protocols. Instead, it functions as an adjunctive step — applied after standard instrumentation and irrigation — to achieve a higher level of disinfection before obturation.
The Picasso Pro unit is compact enough for operatory use without significant space requirements, and the proprietary fibre tips are single-use, addressing cross-contamination concerns that dental professionals in Ontario must navigate under RCDSO IPAC guidelines.
Laser Disinfection in the Context of Digital Dentistry
LEAP arrives at a time when Canadian dental practices are increasingly integrating digital workflows into endodontic care. CBCT imaging, electronic apex locators, and rotary instrumentation systems have already transformed how clinicians approach root canal anatomy. Laser-assisted disinfection fits naturally into this digital-forward approach.
The Canadian Dental Association (CDA) has encouraged the adoption of evidence-based technologies that improve patient outcomes, provided practitioners maintain appropriate training and competency. For practices in Mississauga, Brampton, Markham, Vaughan, and other GTA communities investing in advanced endodontic services, laser disinfection may become a competitive differentiator.
Pro Tip: Before purchasing any laser system, confirm that your malpractice insurance covers laser-assisted procedures and that you have completed the manufacturer's required training certification. The RCDSO expects practitioners to demonstrate competency in any technology they use clinically.
Regulatory Status and Availability
All components of the LEAP system — the Picasso Pro laser, the disinfection solution, and the fibre tips — have received FDA clearance. AMD Lasers formally introduced the system at the 2026 American Association of Endodontists (AAE) Annual Meeting in April 2026.
Canadian availability will depend on Health Canada device licensing. Dental laser systems require Health Canada Medical Device Licence (MDL) approval before they can be marketed in Canada. Practices interested in the technology should monitor Health Canada's Medical Devices Active Licence Listing (MDALL) database for updates on LEAP's Canadian regulatory status.
Cost Considerations
AMD Lasers has not publicly disclosed Canadian pricing for the LEAP system. Dental diode lasers in the Canadian market typically range from $3,000 to $15,000 CAD depending on specifications and included accessories. The per-procedure cost will also include the single-use fibre tips and LEAP disinfection solution, which represent ongoing consumable expenses.
Practices evaluating the investment should weigh the cost against potential reductions in retreatment, improved case acceptance for endodontic procedures (patients are increasingly interested in laser-assisted dentistry), and the marketing value of offering advanced technology in competitive GTA markets.
What the Research Says About Laser-Assisted Endodontic Disinfection
Laser-assisted disinfection in endodontics is not new in concept. Er:YAG and Er,Cr:YSGG lasers have been studied for canal disinfection for over a decade, with systematic reviews published in journals like Dentistry Journal (MDPI) confirming their antimicrobial efficacy. A 2024 randomized clinical trial published in PMC compared Er,Cr:YSGG and 940 nm diode lasers, finding both significantly reduced bacterial loads compared to conventional irrigation alone.
What distinguishes LEAP is its integrated protocol approach — combining a specific laser wavelength, a matched chemical agent, and purpose-built delivery tips — rather than relying on the laser alone. This systems-level design may offer more consistent results across varying canal anatomies and clinician experience levels.
Frequently Asked Questions
Q: Is laser root canal disinfection safe for patients?
Laser-assisted endodontic disinfection has been studied extensively and is considered safe when used according to manufacturer protocols and within established parameters. The diode laser wavelengths used in systems like LEAP are well-characterized in dental literature, and the technology has received FDA clearance. As with any clinical technology, practitioners must complete appropriate training before use.
Q: Will laser disinfection replace traditional sodium hypochlorite irrigation?
Current protocols position laser disinfection as an adjunct to, not a replacement for, conventional irrigation. Standard instrumentation and irrigation with sodium hypochlorite remain foundational steps in endodontic therapy. Laser disinfection adds a supplementary layer of bacterial elimination, particularly in anatomically complex canal systems where irrigants may not fully penetrate.
Q: When will LEAP be available in Canada?
The LEAP system received FDA clearance and was introduced at the April 2026 AAE Annual Meeting. Canadian availability requires Health Canada Medical Device Licence approval, which is a separate regulatory process. Practices can monitor the Health Canada MDALL database for updates on the system's Canadian licensing status.
EBIKO Dental will continue monitoring developments in laser-assisted endodontic technology and Health Canada's regulatory decisions regarding the LEAP system. For updates on advanced dental technologies and clinical supplies, visit ebiko.ca.